Former Medtronic CEO Bill Hawkins Joins Ketryx Board to Address AI Compliance Challenges in Life Sciences

Ketryx, a company specializing in agentic continuous compliance platforms for safety-critical product development, has announced that William A. Hawkins, former Chairman and CEO of Medtronic, has joined its Board of Directors. Hawkins also participated in the company’s Series B financing, signaling strong industry confidence in Ketryx’s mission to solve the AI bottleneck in life sciences.

The announcement, made on June 25, 2026, highlights Ketryx’s focus on helping companies in safety-critical industries—including medical devices, pharmaceuticals, and robotics—accelerate product development. The platform automatically generates compliant documentation, maintains continuous traceability, and enables safe and verifiable AI at scale within the tools teams already use. According to Ketryx, its AI Agents can reduce manual work by up to 90 percent, helping teams identify and close compliance gaps while improving both speed and quality across the product lifecycle.

Hawkins brings extensive experience from his tenure at Medtronic, where he served as Chairman and CEO. His leadership is expected to guide Ketryx as it expands its reach among top medical device manufacturers. The company is already trusted by four of the world’s top five medical device manufacturers, a testament to its ability to transform product lifecycle processes without disrupting existing workflows.

The move comes as the life sciences industry faces increasing pressure to integrate AI while navigating stringent regulatory requirements. Ketryx’s platform overlays existing tools to automate documentation and create traceability, addressing a critical bottleneck in the adoption of AI for safety-critical applications. By automating compliance processes, Ketryx aims to help companies release products faster and more safely.

For more information about Ketryx and its platform, visit www.ketryx.com. The full announcement, including downloadable images and bios, is available here.

This news story relied on content distributed by Reportable. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Former Medtronic CEO Bill Hawkins Joins Ketryx Board to Address AI Compliance Challenges in Life Sciences.

The post Former Medtronic CEO Bill Hawkins Joins Ketryx Board to Address AI Compliance Challenges in Life Sciences appeared first on citybuzz.